Journal of Bacteriology, October 1999, p. 6142-6151, Vol. 181, No. 19
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Department of Microbiology, Michigan State University, East Lansing, Michigan 48824-1101
Received 19 April 1999/Accepted 19 July 1999
| |
ABSTRACT |
|---|
|
|
|---|
Streptomyces coelicolor produces four genetically and
structurally distinct antibiotics in a growth-phase-dependent manner. S. coelicolor mutants globally deficient in antibiotic
production (Abs
phenotype) have previously been isolated,
and some of these were found to define the absB locus. In
this study, we isolated absB-complementing DNA and show
that it encodes the S. coelicolor homolog of RNase III
(rnc). Several lines of evidence indicate that the
absB mutant global defect in antibiotic synthesis is due to
a deficiency in RNase III. In marker exchange experiments, the S. coelicolor rnc gene rescued absB mutants, restoring
antibiotic production. Sequencing the DNA of absB mutants
confirmed that the absB mutations lay in the
rnc open reading frame. Constructed disruptions of
rnc in both S. coelicolor 1501 and
Streptomyces lividans 1326 caused an Abs
phenotype. An absB mutation caused accumulation of 30S rRNA
precursors, as had previously been reported for E. coli rnc
mutants. The absB gene is widely conserved in
streptomycetes. We speculate on why an RNase III deficiency could
globally affect the synthesis of antibiotics.
| |
INTRODUCTION |
|---|
|
|
|---|
The streptomycetes are morphologically complex gram-positive soil bacteria. They are widely important in biotechnology because of the many bioactive secondary metabolites they produce; these include compounds used as antimicrobial, antiviral, antitumor, antiparasitic, and immunosuppressive drugs. Production of these secondary metabolites is temporally and spatially regulated during the complex streptomycete life cycle, occurring in conjunction with the growth of a sporulating aerial mycelium.
Streptomyces coelicolor, the genetically best-characterized species, is a model streptomycete for study of antibiotic regulation (reviewed in references 8 and 15). It is known to produce four antibiotics: actinorhodin (Act), undecylprodigiosin (Red), methylenomycin (Mmy), and calcium-dependent antibiotic (CDA).
Growth-phase regulation of streptomycete secondary metabolites (or, generically, antibiotics) is subject to both global and antibiotic-specific regulation. Transcriptional regulation of each antibiotic's biosynthetic gene cluster depends on a cluster-linked, antibiotic-specific, transcriptional regulator (reviewed in reference 8). The antibiotic-specific regulators, most of which are activators, are themselves subject to growth-phase regulation, being expressed after a period of vegetative growth has elapsed. For S. coelicolor, the characterized antibiotic-specific regulators are actII-ORF4 for Act and redD for Red.
Growth-phase-regulated expression, in both liquid and plate-grown cultures, is apparent for both actII-ORF4 and redD (reviewed in reference 7). Both undergo substantial increases in mRNA abundance after several days of incubation of plate cultures (1) or a period of quasi-exponential growth in defined medium-grown liquid cultures (25, 51). Accumulation of ppGpp is one factor known to be involved in regulating these genes' expression (8, 38), especially in nitrogen-limited media (12). Other regulatory mechanisms that may participate in actII-ORF4 and redD regulation are poorly understood at present.
One approach to characterizing the genetic elements involved in
antibiotic regulation has been to isolate mutants that fail to
produce any of S. coelicolor's known antibiotics but
that do progress normally through the morphogenesis cycle.
Screens for this phenotype, named Abs
(for antibiotic
synthesis negative), yielded mutants of the absA (4) and absB (3) loci.
Examination of actII-ORF4 and redD transcription
in absA and absB Abs
strains has
shown that these mutants are substantially defective in the expression
of the antibiotic regulators (1). The actII-ORF4 and redD expression defect likely accounts for the mutants'
Act
and Red
phenotypes. Expression of
cda and mmy genes has not yet been assessed.
The Abs
phenotype of absA and absB
mutants has suggested that these loci encode components of a regulatory
pathway or network that functions, at least in some conditions, to
coordinately, or globally, regulate S. coelicolor's
antibiotics. The predicted absA gene products, which
comprise a two-component-type signal transduction system
(10), would be candidates for global regulatory elements.
Among other candidates for global regulatory elements are
relA, which encodes ppGpp synthetase (12, 38),
the two-component systems afsQ1/Q2 (28) and
cutR/S (16), the afsRKS locus
(23, 39, 40, 54), which encodes a serine threonine
protein phosphotransfer system, and the mia (14),
abaA (22), and abaB (50)
loci, which encode products of unknown function. An additional set of genes, named bld, regulates morphogenesis (reviewed in
references 15 and 17), as well as
antibiotic synthesis. The functional relationships of these genes are
not yet characterized.
We report here a characterization of the absB locus and
identify the absB gene as the S. coelicolor
homolog of RNase III-encoding genes (rnc). RNase III is an
endonuclease that processes certain double-stranded RNA substrates and
so regulates expression of a set of cellular and bacteriophage genes
and also participates in rRNA processing (19). Sequence
analysis of several mutant absB alleles revealed mutations
that would likely functionally debilitate an RNase III-like protein.
Constructed disruption mutations in absB, both in S. coelicolor and in its close relative Streptomyces lividans, caused the Abs
phenotypes. As in
Escherichia coli RNase III mutants (rnc), an S. coelicolor absB mutant accumulated 30S rRNA precursors.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains, plasmids, and growth conditions.
The
bacterial strains and plasmids used in this study are listed in Tables
1 and 2.
Streptomyces cultures were propagated on R5 agar or in YEME
broth (27) unless otherwise indicated. SMMS medium was as
described previously (25, 51). Thiostrepton (10 µg/ml,
final concentration) or hygromycin (100 µg/ml, final concentration)
was added as needed. Conditions for growth of cultures and preparation
of spore stocks were as described earlier (27). Escherichia coli cultures were grown on Luria-Bertani medium
(48) supplemented with ampicillin (100 µg/ml, final
concentration) as required to maintain plasmids.
|
|
Genetic techniques and DNA manipulations. Streptomyces protoplasts were generated and transformed as described previously (27). Transformants were regenerated on R5, and the selective antibiotic was applied at 18 to 20 h. High-copy-number Streptomyces plasmid DNA was isolated either manually (27) or by using QIAgen Midi Plasmid Columns (Qiagen, Inc.). Low-copy-number plasmid (pIJ922) derivatives were isolated by using the procedure for SCP2* derivatives (27). Chromosomal DNA used for PCR and Southern hybridizations was isolated as described earlier (27). E. coli cultures were transformed as described previously (48). E. coli plasmid DNA was isolated by the alkaline lysis procedure (48) or by QIAprep spin columns (Qiagen, Inc.) when used in automated sequencing. All E. coli plasmids were passed through dam dcm mutant E. coli ET12567 (37) or DM-1 to generate unmethylated DNA suitable for introduction into Streptomyces.
For PCR amplification, Deep Vent polymerase was used (New England Biolabs), and reactions were carried out essentially as recommended by the manufacturer, with the addition of glycerol to a 10% final concentration per reaction. Cycling conditions were as follows: hold at 95°C for 5 min, denature at 96°C for 45 s, anneal at 70°C for 45 s, and extend at 72°C for 1 min for 35 cycles.Cloning the absB locus. The isolation of the absB-encoding DNA was carried out by using a low-copy-number pIJ922 plasmid library (2). The library contained 10- to 30-kb fragments of Sau3A partially digested J1501 chromosomal DNA (10). The cloning scheme took advantage of the self-transmissible nature of pIJ922. M124 protoplasts were transformed with the pIJ922 plasmid library. Thior resistant transformants were replicated onto the lawns of the absB mutant C120 on R5 medium. After sporulation, the mating plates were replicated onto medium selective for C120 recipients and nonpermissive for the M124 host strain (i.e., glucose minimal medium containing uracil, histidine, thiostrepton, and streptomycin). The transconjugants were visually screened for the Act+ Red+ phenotype and subsequently tested for the CDA+ and Mmy+ phenotypes (in SCP1+ derivatives constructed as described in reference 4). Assays for Act, Red, Mmy, and CDA have been described previously (4).
Physical mapping of the absB locus.
The
absB locus was localized on the S. coelicolor
physical map (32, 46) as follows. AseI-digested
J1501 chromosomal DNA was separated by pulsed-field gel electrophoresis
and blotted onto a nitrocellulose membrane (32). The 3.3-kb
PstI fragment from absB complementing clone
pTA108 was random primed labeled (Boehringer Mannheim) with
[
-32P]dCTP for hybridization to the membrane.
High-stringency conditions were used (65°C; 2× SSC [1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate] and 0.5× SSC washes), and the
annealed probe was detected by film exposure for 24 h at
70°C.
Functional analysis of the absB locus through recombinational marker rescue and complementation. Subfragments of the 11.0-kb insert of pTA108 were cloned into the E. coli vector pBluescript KS(+) (Stratagene). In recombinational rescue experiments, fragments were then ligated into the E. coli vector pIJ963 (33), which carries a Hygr gene suitable for selection in Streptomyces. Unmethylated pIJ963 derivatives were used to transform absB mutant strains. Hygr recombinants were isolated (indicating the occurrence of a single crossover event via homologous recombination within the insert) and scored for an Abs+ phenotype 3 to 4 days after transformation. In initial complementation studies, pTA108 fragments were cloned into pIJ2925, which has BglII sites flanking the multiple cloning site (29). After passage through ET12567, clones were digested with BglII to yield unmethylated fragments which were ligated into both the high-copy-number pIJ702 and the low-copy-number pIJ922. In subsequent experiments, the PCR-generated absB gene was amplified by using primers with heterologous BglII sites designed at the ends for cloning directly into pIJ702. In either case, ligation mixtures were used to transform absB mutant C120, and Thior transformants were scored for the Abs+ phenotype. Complementing clones from Abs+ transformants were isolated, and the constructs were confirmed by restriction mapping and Southern hybridization. Complementing clones (e.g., pBK802) were then used to retransform C120 and to transform other absB mutant strains, as well as wild-type J1501. PCR-generated absB mutant alleles were similarly cloned (e.g., pBK803 and pBK804) and introduced back into their respective absB mutant backgrounds as a negative control for complementation.
DNA sequencing and analysis.
Automated sequencing of the
absB locus from wild-type and absB mutant strains
was performed at the Iowa State University and the Michigan State
University sequencing facilities. Nested deletion clones from pBK210
and PCR-generated fragments were used as sequencing templates. PCR
primers A and D (see Fig. 2) were used to generate templates of the
absB gene from wild-type and mutant strains; these were
functionally characterized by complementation (see above) and were also
cloned into pBluescript SK(+) (pBK802 to pBK804 and pRK805) for
sequencing with standard universal and reverse primers and primer B
(see Fig. 2). All sequencing templates were purified by using QIAprep
Spin Columns and were resuspended in water to a concentration of
200
ng/µl. When necessary, 10% glycerol or 10% dimethyl sulfoxide was
added to the cycling reaction mixtures to aid sequencing through
regions of complex secondary structure. Sequence data was compiled and
analyzed by using the Wisconsin Package version 9 (Genetics Computer
Group [GCG], Madison, Wis.).
Construction of the absB disruption mutants. An internal fragment of the wild-type J1501 absB gene was generated by PCR with primers B and IF (see Fig. 2) to yield a 455-bp fragment. This fragment was gel purified (QIAquick), BglII digested, and ligated into pIJ963 to generate pBK314 (see Fig. 7). Unmethylated plasmid was generated from E. coli DM-1 and subsequently used to transform J1501 as well as S. lividans 1326. To increase efficiency of integrative transformation, alkali treatment of plasmid DNA was used, as described elsewhere (44). Hygr transformants were isolated, and disruption of the absB gene was confirmed by Southern hybridization by using the absB and Hygr genes as probes (data not shown).
Identifying absB homologs in other streptomycetes. Chromosomal DNA was isolated from various Streptomyces strains (27) and digested with BglII, BamHI, or PstI. Normalized amounts of digested DNA (50 µg/lane) were electrophoresed on a 0.7% agarose gel. Southern blotting was performed as described previously (48). A 1.0-kb PstI fragment from E. coli clone pBK802 containing the wild-type absB gene was gel purified (QIAquick) and labeled with digoxigenin-UTP. Probe preparation, nonradioactive hybridization, and colormetric detection was performed by using the Genius Kit (Boehringer Mannheim) under high-stringency conditions according to the manufacturer's instructions.
Identification of 30S precursor rRNA. RNA samples isolated over a 65-h time course from J1501, C120 (absB), and C120-310 (absB120::pBK310) were isolated as described previously (1). Then, 50 µg of each RNA sample was run on 1.5% agarose at 25 V for 16 h. The gel was stained with ethidium bromide and photographed.
Nucleotide sequence accession number. The nucleotide sequence of absB has been assigned EMBL accession no. Q9ZBQ7.| |
RESULTS |
|---|
|
|
|---|
Cloning and physical mapping of the absB locus.
Genetic analysis of a collection of absB mutants had
suggested that a single mutant locus was responsible for the
Abs
(e.g., Act
Red
Mmy
CDA
) phenotype of the strains
(3). To clone the wild-type absB locus, a
low-copy-number plasmid library of J1501 chromosomal DNA partially
digested by Sau3A was screened for complementation of the
C120 absB mutant strain (see Materials and Methods).
Localization of absB within a complementing fragment. To delimit the putative absB gene within the inserts of the complementing clones pTA108 and pTA128, the shared PstI fragments (which are the 3.3- and 2.6-kb PstI fragments in Fig. 1) were isolated from pKJ100 and tested for the ability to restore the wild-type phenotype (Abs+) to strain C120. Each was ligated into pBluescript KS(+) to assist in further cloning, yielding pBK200 (as described above) and pBK210, respectively. PstI fragments were then cloned from these vectors into pIJ963, an E. coli plasmid carrying an Hygr cassette suitable for selection in Streptomyces, to yield pBK300 and pBK310 (Fig. 1). Since pIJ963 cannot replicate in Streptomyces, Hygr colonies could arise only after homologous recombination within the cloned insert. Hygr colonies of the absB mutant C120 could be expected to display the Abs+ phenotype if the cloned insert contained at least one end of the absB gene and included the region spanning the absB mutation.
|
. This suggested that the absB+
DNA lay in the 2.6-kb PstI interval of Fig. 1. To further
subdivide this interval, a convenient ApaI restriction site
located within the 2.6-kb fragment was used to generate 1.4- and 1.2-kb
PstI-ApaI fragments from pBK210, which were
subcloned into pBluescript KS(+) to yield pBK212 and pBK213,
respectively. Each insert was recovered as a
KpnI-BamHI fragment and ligated into pIJ963 to
yield pBK312 (1.4 kb) and pBK313 (1.2 kb) (Fig. 1). After
transformation of C120, 16 of 25 of the recombinants from pBK312 were
Abs+ and four of four of the pBK313 recombinants were
Abs
. These results suggested that
absB+ DNA was contained within the 1.4-kb
PstI-ApaI fragment and may have been truncated or
lacked the promoter.
To obtain some indication as to whether the 1.4-kb
PstI-ApaI fragment had the ability to complement
absB mutations in trans, the autonomously
replicating Streptomyces plasmids pIJ702 (high copy number)
and pIJ922 (low copy number) were used. The 1.4-kb PstI-ApaI fragment was cloned into pIJ2925, and a
BglII fragment was recovered and cloned into both pIJ702 and
pIJ922. Recombinant plasmid DNAs from both the low-copy-number pIJ922
clone (named pBK600) and the high-copy-number pIJ702 clone (pBK650)
were then used to transform C120. All of the transformants grew as
uniformly Abs+ colonies, suggesting that the 1.4-kb
fragment contained the complete absB+ gene and
did not require recombinational repair with the chromosome to produce a
functional gene. Both pBK600 and pBK650 complemented other
absB mutants as well. These results further suggested that all of the absB mutations had created recessive,
loss-of-function alleles.
DNA sequence analysis of the 2.6-kb PstI fragment in pBK310
revealed three open reading frames (ORFs) by using CODON PREFERENCE (Fig. 1). The 3' end of the 2.6-kb fragment contained a truncated 306-bp ORF, designated orfX, that showed no homology to any
sequences in the protein databases. A second ORF, spanning the
ApaI site in Fig. 1, showed homology (57.5% similarity and
31.6% identity) to several formamidopyrimidine DNA glycosylase
(fpg) genes in the databases. The Fpg protein (also named
MutM in E. coli) is a DNA repair enzyme that excises the
imidizole ring-opened form of N7-methylguanine from damaged DNA
(7). We have similarly designated this ORF fpg.
A third ORF (Fig. 2) was found to be
contained entirely within the 1.4-kb PstI-ApaI
fragment that recombinationally rescued and complemented
absB mutants as discussed above; it therefore was a strong
candidate for the absB gene. This 276-amino-acid ORF showed
41% identity to E. coli RNase III (Fig.
3), which is encoded by the
rnc gene. Several other RNase III homologs were also found
in the databases; amino acid alignments of six of these homologs are
shown in Fig. 3. The double-stranded RNA binding domain (31)
is strictly conserved in the S. coelicolor sequence, as are
all of the functionally significant residues defined for the E. coli RNase III homolog (Fig. 3), notably, a 10-amino-acid box
containing the amino acid which is altered in the well-studied rnc105 allele (42a), as well as the nearly
invariant glutamic acid residue altered in the rnc70 allele
(27a).
|
|
Identification of the absB gene. Of the ORFs located within the sequenced region, the one encoding the RNase III homolog was the best candidate for the absB gene. To specifically test this ORF for complementation of absB mutations, PCR primers A and D (Fig. 2) were used to generate a 1,046-bp fragment from wild-type strain J1501 which would contain the RNase III ORF and the noncoding regions on either side of the gene. The BglII-digested fragment's sequence was confirmed, and it was ligated with the high-copy-number plasmid pIJ702. A representative plasmid, pBK651, was transformed into C120; it gave 100% Abs+ colonies (n = 264). Subsequent transformation into other absB mutants, C175 and C170, gave similar results. The BglII fragment from pBK651 was also cloned into low-copy-number pIJ922; the resulting clone, pIJ601, was able to restore the Abs+ phenotype to each of the absB mutants.
To determine whether absB mutants contained mutational alterations to the RNase III-like gene, this gene was sequenced in three absB mutants: C120, C252, and C175 (Table 1). Primers A and D (Fig. 2) were used to amplify the 1,046-bp fragment corresponding to that amplified from J1501 as described above; each reaction generated a fragment the same size as the J1501 fragment, indicating that no major deletions of the locus were responsible for the Abs
phenotype. PCR fragments generated in replicate
from independent amplification reactions were sequenced. Sequence
comparisons showed that the sequence amplified from each mutant
contained an alteration (Fig. 2) and that these mutations could
predictably disrupt the production or function of an RNase III-like
protein. Strain C120 contained a C
T transition that would change
Leu172 to a proline residue. This amino acid lies within
the first
-helix of the putative double-stranded RNA binding domain
(dsRBD) (32); the presence of a proline residue would likely
disrupt the structural integrity of an
-helix. The C175 allele
contained two adjacent base-pair changes, the second of which resulted
in a nonsense mutation at Lys8. The C252 allele contained a
7-bp duplication of nucleotides (nt) 505 to 511; hence, this mutation
would introduce a frameshift.
Two of the PCR-amplified absB mutant alleles were cloned
into pIJ702 in both orientations for complementation testing.
Representative clones were named pBK652 (absB120) and pBK653
(absB175). Unlike the wild-type allele, neither mutant
allele was able to complement the absB mutant phenotype
(C120, n = 137; C175, n = 88), as expected.
Genetic organization of the absB locus. Comparison of the absB sequence to the S. coelicolor genome sequence (49) revealed that absB lay within cosmid 7A1 (46). The locations of neighboring ORFs suggested a possible absB operon structure: this may include the two ORFs upstream of absB (Fig. 4A). The ORF left of absB is predicted to encode the 50S ribosomal protein L32 and hence would be named rpmF; these two ORFs are separated by 20 nt and therefore may be cotranscribed. The ORF left of the rpmF gene (SC7A1.14) corresponds to an unknown Mycobacterium tuberculosis gene (49). This ORF is separated by only 3 nt from rpmF and so is likely to be cotranscribed with rpmF and absB. The region separating SC7A1.14 from the next neighboring (leftwards) ORF (SC7A1.13), which encodes another unknown protein, is 145 nt: this distance suggests independent transcription of the two genes. Finally, the 110-nt intergenic region separating absB from the rightwards fpg ORF contains a 20-bp perfect inverted repeat likely to function as a terminator of the absB transcript.
|
Disruption of absB in S. coelicolor and S. lividans. Despite the important functions of RNase III in processing ribosomal precursor RNAs, as well as many cellular RNAs, E. coli RNase III is not essential for viability (6, 53). In contrast, the Bacillus subtilis rnc gene could not be disrupted (55). Therefore, it was of interest to evaluate whether S. coelicolor required absB function. The viability of the nonsense and frameshift absB mutant strains, C175 and C252, respectively, strongly predicted that absB was not essential to S. coelicolor. However, it was conceivable that these strains might contain suppressive mutations. Therefore, a constructed disruption of the absB gene was produced.
To create a disruption in the absB gene, a 455-bp fragment internal to the gene was amplified by using primers B and IF (Fig. 2), as described in Materials and Methods. The fragment was ligated into pIJ963, a plasmid lacking a Streptomyces replicon (Table 1), to produce pBK314 (Fig. 4). A single crossover via homologous recombination of the cloned absB fragment and the chromosomal absB gene would create two truncated copies of absB flanking the plasmid vector (Fig. 4B). The absB 3' truncation would eliminate the dsRNA binding motif, and the absB 5' truncation would be expected to eliminate transcription and, moreover, the N-terminal 10-amino-acid conserved motif of any residually produced protein. A representative S. coelicolor J1501 absB disruptant, named C23, displayed a phenotype much like that of the C175 and C252 nonsense and frameshift strains, being deficient in antibiotic production but able to form a sporulating aerial mycelium. These strains' antibiotic-minus phenotype was more severe than that of the C120 missense strain, especially on complex media such as R5. Although C120 grew as well as the J1501 parent, C23, C175, and C252 formed smaller colonies on both R5 medium and minimal SMMS medium. A representative disruptant of S. lividans 1326, named C24, also displayed an Abs
phenotype, failing to produce any
observable pigment, but forming a sporulating aerial mycelium.
absB is conserved in various streptomycetes. To determine whether the absB gene is conserved across species, a 1.0-kb PstI fragment from clone pBK802, containing the entire absB ORF, was used to probe the chromosomal DNA of various streptomycetes (data not shown). A PstI digest of prototrophic strain S. coelicolor M600 and PstI and BglII digests of the S. coelicolor parent strain J1501 were used as positive controls. For each digest, a single band was visible at 2.6 or 8.1 kb respectively, as predicted from the pTA108 restriction map (Fig. 1), indicating a single RNase III-encoding gene in S. coelicolor. In other streptomycete species, a single BamHI fragment hybridized to the probe under high-stringency conditions; fragments from Streptomyces albus (2.4 kb), Streptomyces ambofaciens 2035 (6.5 kb), Streptomyces avermitilis (9.1 kb), and Streptomyces cinnamonium (8.8 kb) were detected. The hybridization conditions used (0.5× SSC-0.1% sodium dodecyl sulfate at 65°C) predictably exclude probe binding under 90% homology according to the manufacturer. The identity between the absB genes of S. coelicolor and the actinomycete M. tuberculosis is 62.2%, and it is not surprising that like genes of the streptomycetes would have greater degrees of homology.
30S rRNA precursors in absB mutant strain. One distinguishing characteristic of an E. coli rnc mutant is the presence of the 30S precursor rRNA in total RNA preparations (6, 21). This precursor accumulates only in RNase III-minus mutants, owing to inefficient processing in the absence of the enzyme. To determine whether rRNA processing was deficient in an absB mutant, RNAs isolated at various time points from J1501, C120, and the Abs+ recombinant C120-310 were run on a 1.5% agarose gel. At each time point, an additional rRNA band with migration consistent with 30S rRNA (6) was seen in the absB mutant but not in either Abs+ strain (Fig. 5). The abundance of 30S precursor decreased at later times, an effect also observed in two independently isolated RNA time courses. This result provided evidence that the putative Streptomyces RNase III homolog has retained the rRNA processing function defined for other RNase III enzymes and that this function is inhibited in the absB mutant strain C120.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study we have identified and partially characterized the
S. coelicolor absB gene and have presented evidence that it
encodes the S. coelicolor homolog of RNase III, a
dsRNA-specific endoribonuclease. Through recombinational rescue and
complementation experiments, we have shown that S. coelicolor
absB mutants can be restored to the wild-type Abs+
phenotype by the introduction of the wild-type RNase III-like gene.
Sequence analysis of three absB mutant strains showed that each harbors a mutation in the putative RNase III-encoding gene. One
mutation is an N-terminal nonsense mutation, the second introduces a
frameshift upstream of the predicted dsRNA-binding motif, and the third
would likely alter the secondary structure of the dsRNA-binding motif.
In addition, disruption of the absB gene produced a mutant with a tight Abs
phenotype, e.g., the strain produced no
detectable antibiotics but did sporulate like its parental strain, J1501.
What is the mechanism by which absB regulates production of all four S. coelicolor antibiotics? Previous work has shown that the defect in antibiotic production in absB mutants is at least partially the result of a defect in expression of the antibiotic genes (1). The levels of transcripts expressed from the actinorhodin and undecylprodigiosin gene clusters, including act biosynthetic transcripts and the antibiotic-pathway-specific regulators actII-ORF4 and redD, were found to be notably decreased by the absB120 missense mutation. (We do not know if the C175, C252, and C23 strains would show even stronger effects on antibiotic gene expression.) Moreover, extra plasmid-cloned copies of actII-ORF or redD restored, respectively, abundant Act or Red production to absB mutants (2, 14). Perhaps AbsB is needed for stabilization of the pathway-specific regulator transcripts, possibly to achieve a certain threshold level, after which antibiotic biosynthetic gene transcription can occur. Alternatively, AbsB may regulate a regulator of actII-ORF4 and redD transcription. It should be noted that this work does not distinguish whether RNase III in S. coelicolor directly regulates antibiotic gene expression by specific mRNA processing or whether the antibiotic gene expression defect of the absB mutants is an indirect effect. However, the ability of the absB mutants to sporulate normally indicates the absence of a global perturbation to colony development and differentiation. Thus, absB may affect expression of a gene required for expression of the set of pathway-specific regulators.
Prediction of candidate targets for S. coelicolor RNase III
is difficult: although many RNase III processing targets have been
identified in E. coli and other systems, the specific
structural and sequence determinants required for RNase III-dependent
cleavage have eluded definition. Most substrates contain an ~20-bp
double-helical region. Stem-loop structures are found in almost all RNA
molecules, but the vast majority are not processed by RNase III. RNase
III apparently does not respond to a consensus sequence as a processing substrate. Rather, recent work suggests that certain Watson-Crick base
pairs at specific sites in an RNase III substrate function as RNase III
antideterminants, inhibiting enzymatic cleavage (56). In
vivo, the wild-type RNase III may even be able to influence gene
expression as a result of binding RNA, without RNA processing, as
suggested in the case of cIII and int regulation
in phage
(20, 45).
RNase III has been best characterized in E. coli, where it was first identified by its ability to degrade long duplex RNA (reviewed in reference 19). Later, RNase III was shown to process phage T7 mRNA and to initiate the processing of the 30S rRNA precursor into the mature 16S and 23S subunits. The 30S rRNA precursor is seen only in strains devoid of RNase III activity, since the processing occurs very rapidly during transcription in wild-type strains.
In an initial functional characterization of the putative RNase III in S. coelicolor, we analyzed preparations of rRNA from the wild-type J1501 and the C120 absB mutant strain: a large RNA corresponding in size to the 30S rRNA precursor was seen in the absB mutant C120 but not in the wild-type J1501 or in C120 recombinationally rescued to the Abs+ phenotype with pBK310 (C120-310). This result suggested that the absB gene product processes 30S precursor rRNA in addition to its function in antibiotic production.
The gene that encodes RNase III in E. coli, rnc, is not essential for growth. In rnc mutant strains, the mature 16S rRNA is formed by a redundant mechanism and, although mature 23S rRNA never forms, the 50S ribosomes containing immature pre-23S rRNA are competent for translation (34). E. coli rnc mutants grow at a lower rate than rnc+ strains, with the extent of the growth defect varying depending on the culture medium and genetic background (6). In S. coelicolor, we have observed a smaller colony size in absB mutants, not only in the C23 absB disruption strain but also in the absB nonsense mutant C175 and the absB frameshift mutant C252, compared to those of the wild-type J1501 and the absB missense mutant C120. In contrast to E. coli and S. coelicolor, the B. subtilis RNase III may be essential for viability since extensive attempts to construct a null mutant were unsuccessful (55).
It is notable that the genetic organization of the absB
locus is quite different than the E. coli or B. subtilis rnc operon structures. The B. subtilis operon
organization is rnc smc srb (43); SMC is a
chromosome condensing protein, and srb is a homologue of the
mammalian SRP receptor
-subunit. In E. coli,
rnc is cotranscribed (53) with era, an
essential gene that encodes a GTPase involved in cell cycle
progression, and with recO.
Besides its role in rRNA processing, RNase III affects the half-life
and functional activity of numerous mRNAs. It has been estimated that
the abundance of as many as 10% of E. coli proteins detectable by gel analysis are either under- or overproduced in the
well-characterized rnc105 mutant (24). Through
endonucleolytic cleavage of stem-loop structures within the 5' or 3'
noncoding regions of certain mRNAs, RNase III is able to up- or
downregulate the expression of genes posttranscriptionally
(19). In some examples from phage, RNase III has been shown
to cleave stem-loops in the leader RNA of the N protein transcript and
in the 3' end of the int gene transcript. Processing
enhances
N gene expression by opening up a Shine-Dalgarno sequence
for translation initiation but reduces
int gene
expression by exposing the transcript to exonucleolytic degradation.
The T7 phage early and late gene transcripts have RNase III processing
signals in intercistronic regions; specific cleavages yield mature
mRNAs that have increased translational activity and stability. In an
exmaple from E. coli, RNase III processing of the alcohol
dehydrogenase mRNA (adhE) is essential for its translation
and, hence, for cell growth in anaerobic conditions (5a).
Among the E. coli cellular genes regulated by RNase III is
rnc itself. This autoregulation involves processing of the
rnc transcript's 5' leader (41). Measurements of
RNase III protein levels suggest that RNase III molecules are present
in an amount similar to that of
factor (reviewed in reference
19). Fluctuations in substrate levels, especially
rRNA, may therefore affect RNase III levels. Additional RNase
III-independent, posttranscriptional, growth rate controls on RNase III
levels have also been observed (11).
It will be interesting to determine whether the level or activity of the S. coelicolor absB gene or gene product varies with respect to growth phase. If absB is transcribed as part of an operon with the ribosomal protein rpmF (Fig. 4), regulation at that promoter would not be expected. However, a potential target for posttranscriptional autoregulation is the long stem-loop 3'-wards of the gene (Fig. 2).
The RNase III homologue described here adds to the growing list of streptomycete mRNA processing enzymes identified: others include polynucleotide phosphorylase (30) and RNase ES (26), a single-strand-specific endoribonuclease that has E. coli RNase E-like cleavage specificity and biochemical characteristics. These enzymes' in vivo substrates have not yet been identified, but an interesting observation regarding RNase ES is that its activity increases as S. coelicolor cultures age. Moreover, the increase is dependent on a developmental gene, bldA (35), suggesting that the RNase E-like enzyme activity may be important to developmental regulation. Clearly, further analyses of the roles of RNA processing enzymes will be important in understanding developmental regulation.
Considering the wide distribution of putative RNase III genes among various streptomycetes, it will be interesting to determine whether mutations to the homologous genes perturb antibiotic synthesis, as occurs in S. coelicolor and its close relative, S. lividans.
| |
ACKNOWLEDGMENTS |
|---|
We thank Helen Kieser for assistance in running the pulsed-field gels, Kelly Spencer for her contributions to restriction site mapping, Dave Aceti for RNA isolations, and Paul Brian and Jamie Ryding for assistance with sequence analysis.
This work was supported by grants MCB9306676 and MCB9604055 to W.C. from the National Science Foundation. B.P. received support from a National Institutes of Health Biotechnology Training Grant.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Giltner Hall, Michigan State University, East Lansing, MI 48824-1101. Phone: (571) 353-9770. Fax: (571) 353-8957. E-mail: champnes{at}pilot.msu.edu.
Present address: Abbott Laboratories, Abott Park, Ill.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aceti, D. J., and W. C. Champness.
1998.
Transcriptional regulation of Streptomyces coelicolor pathway-specific antibiotic regulation by the absA and absB loci.
J. Bacteriol.
180:3100-3106 |
| 2. | Adamidis, A. 1994. Ph.D. dissertation. Michigan State University, East Lansing. |
| 3. |
Adamidis, T., and W. Champness.
1992.
Genetic analysis of absB, a Streptomyces coelicolor locus involved in global antibiotic regulation.
J. Bacteriol.
174:4622-4628 |
| 4. |
Adamidis, T.,
P. Riggle, and W. Champness.
1990.
Mutations in a new Streptomyces coelicolor locus which globally block antibiotic biosynthesis but not sporulation.
J. Bacteriol.
172:2962-2969 |
| 5. |
Apirion, D., and N. Watson.
1975.
Mapping and characterization of a mutation in Escherichia coli that reduces the level of ribonuclease III specific for double-stranded ribonucleic acid.
J. Bacteriol.
124:317-324 |
| 5a. |
Aristarkov, A.,
A. Mikulskis,
J. G. Belasco, and E. C. C. Lin.
1996.
Translation of the adhE transcript to produce ethanol dehydrogenase requires RNase III cleavage in Escherichia coli.
J. Bacteriol.
178:4327-4332 |
| 6. |
Babitzke, D.,
L. Granger,
J. Olszewski, and S. R. Kushner.
1993.
Analysis of mRNA decay and rRNA processing in Escherichia coli multiple mutants carrying a deletion in RNase III.
J. Bacteriol.
175:229-239 |
| 7. | Bardwell, J. C., P. Regnier, S. M. Chen, Y. Nakamura, M. Grunberg-Manago, and D. L. Court. 1989. Autoregulation of RNase III operon by mRNA processing. EMBO J. 8:3401-3407[Medline]. |
| 8. | Bibb, M. 1996. 1995 Colworth Prize Lecture. The regulation of antibiotic production in Streptomyces coelicolor A3(2). Microbiology 142:1335-1344[Medline]. |
| 9. | Boiteux, S., E. Gajewski, J. Laval, and M. Dizdaroglu. 1992. Substrate specificity of the Escherichia coli Fpg protein (formamidopyrimidine-DNA glycosylase): excision of purine lesions in DNA produced by ionizing radiation or photosensitization. Biochemistry 31:106-110[Medline]. |
| 10. |
Brian, P.,
P. J. Riggle,
R. A. Santos, and W. C. Champness.
1996.
Global negative regulation of Streptomyces coelicolor antibiotic synthesis mediated by an absA-encoded putative signal transduction system.
J. Bacteriol.
178:3221-3231 |
| 11. | Britton, R. A., B. S. Powell, S. Dasgupta, Q. Sun, W. Margolin, J. R. Lupski, and D. L. Court. 1998. Cell cycle arrest in Era GTPase mutants: a potential growth rate regulated cell cycle checkpoint in Escherichia coli. Mol. Microbiol. 27:739-750[Medline]. |
| 12. |
Chakraburtty, R., and M. Bibb.
1997.
The ppGpp synthetase gene (relA) of Streptomyces coelicolor A3(2) plays a conditional role in antibiotic production and morphological differentiation.
J. Bacteriol.
179:5854-5851 |
| 13. |
Champness, W. C.
1988.
New loci required for Streptomyces coelicolor morphological and physiological differentiation.
J. Bacteriol.
170:1168-1174 |
| 14. | Champness, W., P. Riggle, T. Adamidis, and P. Vandervere. 1992. Identification of Streptomyces coelicolor genes involved in regulation of antibiotic synthesis. Gene 115:55-60[Medline]. |
| 15. | Champness, W. C., and K. F. Chater. 1994. Regulation and integration of antibiotic production and morphological differentiation in Streptomyces spp., p. 61-93. In P. J. Piggot, J. Moran, C. P., and P. Youngman (ed.), Regulation of bacterial differentiation. American Society for Microbiology, Washington, D.C. |
| 16. | Chang, H.-M., J. Y. Chen, Y. T. Shieh, M. J. Bibb, and C. W. Chen. 1996. The cutRS signal transduction system of Streptomyces lividans represses the biosynthesis of the polyketide antibiotic actinorhodin. Mol. Microbiol. 21:1075-1085[Medline]. |
| 17. | Chater, K. F. 1998. Taking a genetic scalpel to the Streptomyces colony. Microbiology 144:1465-1478. |
| 18. | Chater, K. F., and M. J. Bibb. 1997. Regulation of bacterial antibiotic production, p. 57-105. In H. Kleinkauf, and H. von Döhren (ed.), Products of secondary metabolism, vol. 6. (Biotechnology). VCH, Weinheim, Germany. |
| 19. | Court, D. 1993. RNA processing and degradation by RNase III, p. 71-116. In J. G. Belasco, and G. Brawerman (ed.), Control of messenger RNA stability. Academic Press, San Diego, Calif. |
| 20. |
Dasgupta, S.,
L. Fernendez,
L. Kameyama,
T. Inada,
Y. Kakamura,
A. Pappas, and D. L. Court.
1998.
Genetic uncoupling of the dsRNA binding and RNA cleavage activities of the Escherichia coli endoribonuclease RNase III the effect of dsRNA binding on gene expression.
Mol. Microbiol.
28:629-640[Medline].
|
| 21. |
Dunn, J. J., and F. W. Studier.
1973.
T7 early RNAs and Escherichia coli ribosomal RNAs are cut from large precursor RNAs in vivo by ribonuclease 3.
Proc. Natl. Acad. Sci. USA
70:3296-3300 |
| 22. | Fernendez-Moreno, M. A., A. J. Martin-Triana, E. Martinez, J. Niemi, H. M. Kieser, D. A. Hopwood, and F. Malpartida. 1992. abaA, a new pleiotropic regulatory locus for antibiotic production in Streptomyces coelicolor. J. Bacteriol. 174:2956-2967. |
| 23. | Floriano, B., and M. J. Bibb. 1996. afsR is a pleiotropic but conditionally required regulatory gene for antibiotic production in Streptomyces coelicolor A3(2). Mol. Microbiol. 21:385-396[Medline]. |
| 24. | Gitelman, D. R., and D. Apirion. 1980. The synthesis of some proteins is affected in RNA processing mutants of Escherichia coli. Biochem. Biophys. Res. Commun. 96:1063-1070[Medline]. |
| 25. | Gramajo, H. E., E. Takano, and M. J. Bibb. 1993. Stationary phase production of the antibiotic actinorhodin in Streptomyces coelicolor A3(2) is transcriptionally regulated. Mol. Microbiol. 7:837-845[Medline]. |
| 26. | Hagige, J. M., and S. N. Cohen. 1997. A developmentally regulated Streptomyces endoribonuclease resembles ribonuclease E of Escherichia coli. Mol. Microbiol. 25:1077-1090[Medline]. |
| 27. | Hopwood, D. A., M. J. Bibb, K. F. Chater, T. Kieser, C. J. Bruton, H. M. Kieser, D. J. Lydiate, C. P. Smith, J. M. Ward, and H. Schrempf. 1985. Genetic manipulation of Streptomyces: a laboratory manual, 1st ed. The John Innes Foundation, Norwich, United Kingdom. |
| 27a. |
Inada, T.,
K. Kawakami,
S. Chen,
H. Takiff,
D. Court, and Y. Nakamura.
1989.
Temperature-sensitive lethal mutant of Era, a G-protein in Escherichia coli.
J. Bacteriol.
171:5017-5024 |
| 28. |
Ishizuka, H.,
S. Horinouchi,
H. M. Kieser,
D. A. Hopwood, and T. Beppu.
1992.
A putative two-component regulatory system involved in secondary metabolism in Streptomyces spp.
J. Bacteriol.
174:7585-7594 |
| 29. | Janssen, G. R., and M. J. Bibb. 1993. Derivatives of pUC18 that have BglII sites flanking a modified multiple cloning site and that retain the ability to identify recombinant clones by visual screening of Escherichia coli colonies. Gene 124:133-134[Medline]. |
| 30. |
Jones, G. H., and M. J. Bibb.
1996.
Guanosine pentaphosphate synthetase from Streptomyces antibioticus is also a polynucleotide phosphorylase.
J. Bacteriol.
178:4281-4288 |
| 31. | Kharrat, A., M. J. Macias, T. J. Gibson, M. Nilges, and A. Pastore. 1995. Structure of the dsRNA binding domain of E. coli RNase III. EMBO J. 14:3572-3584[Medline]. |
| 32. |
Kieser, H. M.,
T. Kieser, and D. A. Hopwood.
1992.
A combined genetic and physical map of the Streptomyces coelicolor A3(2) chromosome.
J. Bacteriol.
174:5496-5507 |
| 33. | Kieser, T. Personal communication. |
| 34. |
King, T. C.,
R. Sirdeshmukh, and D. Schlessinger.
1984.
RNase III cleavage is obligate for maturation but not for function of Escherichia coli pre-23S rRNA.
Proc. Natl. Acad. Sci. USA
81:185-188 |
| 35. |
Lawlor, E. J.,
H. A. Baylis, and K. F. Chater.
1987.
Pleiotropic morphological and antibiotic deficiencies result from mutations in a gene encoding a tRNA-like product in Streptomyces coelicolor A3(2).
Genes Dev.
1:1305-1310 |
| 36. | Lydiate, D. J., F. Malpartida, and D. A. Hopwood. 1985. The Streptomyces plasmid SCP2*: its functional analysis and development into useful cloning vectors. Gene 35:223-235[Medline]. |
| 37. | MacNeil, D. J., K. M. Gewain, C. L. Ruby, G. Dezeny, P. H. Gibbons, and T. MacNeil. 1992. Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector. Gene 111:61-68[Medline]. |
| 38. |
Martinez-Costa, O.,
H. P. Arian,
N. M. Romero,
V. Parro,
R. P. Mellado, and F. Malpartida.
1996.
A relA/spoT homologous gene from Streptomyces coelicolor A3(2) controls antibiotic biosynthetic genes.
J. Biol. Chem.
271:10627-10634 |
| 39. | Matsumoto, A., S. K. Hong, H. Ishizuka, S. Horinouchi, and T. Beppu. 1994. Phosphorylation of the AfsR protein involved in secondary metabolism in Streptomyces species by a eukaryotic-type protein kinase. Gene 146:47-56[Medline]. |
| 40. | Matsumoto, A., H. Ishizuka, T. Beppu, and S. Horinouchi. 1995. Involvement of a small ORF downstream of the afsR gene in the regulation of secondary metabolism in Streptomyces coelicolor A3(2). Actinomycetologica 9:37-43. |
| 41. | Matsunaga, J., E. L. Simons, and R. W. Simons. 1996. RNase III autoregulation: structure and function of rncO, the posttranscriptional "operator." RNA 2:1228-1240[Abstract]. |
| 42. | Merrick, M. J. 1976. A morphological and genetic mapping study of bald colony mutants of Streptomyces coelicolor. J. Gen. Microbiol. 96:299-315[Medline]. |
| 42a. | Nashimoto, H., and H. Uchida. 1985. DNA sequencing of the Escherichia coli ribonuclease III gene and its mutations. Mol. Gen. Genet. 201:25-29[Medline]. |
| 43. |
Oguro, A.,
H. Kakeshita,
H. Takamatsu,
K. Nakamura, and K. Yamane.
1996.
The effect of Srb, a homologue of the mammalian SRP receptor -subunit, on Bacillus subtilis growth and protein translocation.
Gene
172:17-24[Medline].
|
| 44. |
Oh, S. H., and K. F. Chater.
1997.
Denaturation of circular or linear DNA facilitates targeted integrative transformation of Streptomyces coelicolor A3(2): possible relevance to other organisms.
J. Bacteriol.
179:122-127 |
| 45. | Oppenheim, A., O. Kornitzer, S. Altuvia, and D. Court. 1993. Posttranscriptional control of the lysogenic pathway in bacteriophage lambda. Prog. Nucleic Acid Res. Mol. Biol. 46:37-49[Medline]. |
| 46. | Redenbach, M., H. M. Kieser, D. Denapaite, A. Eichner, J. Cullum, H. Kinashi, and D. A. Hopwood. 1996. A set of ordered cosmids and a detailed genetic and physical map for the 8 Mb Streptomyces coelicolor A3(2) chromosome. Mol. Microbiol. 21:77-96[Medline]. |
| 47. | Saito, H., and C. C. Richardson. 1981. Processing of mRNA by ribonuclease III regulates expression of gene 1.2 of bacteriophage T7. Cell 27:533-542[Medline]. |
| 48. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 49. | Sanger Center Streptomyces coelicolor Sequencing Project. [Online.] Sanger Center. http://www.sanger.ac.uk/Projects/S_coelicolor/. [31 August 1999, last date accessed.] |
| 50. | Schen, A.-K., E. Martínez, J. Soliveri, and F. Malpartida. 1997. abaB, a putative regulator for secondary metabolism in Streptomyces. FEMS Microbiol. Lett. 177:29-36. |
| 51. | Takano, E., H. C. Gramajo, E. Strauch, N. Andres, J. White, and M. J. Bibb. 1992. Transcriptional regulation of the redD transcriptional activator gene accounts for growth-phase-dependent production of the antibiotic undecylprodigiosin in Streptomyces coelicolor A3(2). Mol. Microbiol. 6:2797-2804[Medline]. |
| 53. |
Takiff, H. E.,
S. M. Chen, and D. L. Court.
1989.
Genetic analysis of the rnc operon of Escherichia coli.
J. Bacteriol.
171:2581-2590 |
| 54. | Vogtli, M., P.-C. Chang, and S. N. Cohen. 1994. afsR: a previously undetected gene encoding a 63-amino-acid protein that stimulates antibiotic production in Streptomyces lividans. Mol. Microbiol. 14:643-654[Medline]. |
| 55. |
Wang, W., and D. H. Bechhofer.
1997.
Bacillus subtilis RNase III gene: cloning, function of the gene in Escherichia coli, and construction of Bacillus subtilis strains with altered rnc loci.
J. Bacteriol.
179:7379-7385 |
| 56. |
Zhang, K., and A. W. Nicholson.
1997.
Regulation of ribonuclease III processing by double-helical sequence antideterminants.
Proc. Natl. Acad. Sci. USA
94:13437-13441 |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||